A Long-term Safety Extension Study of Tocilizumab in Brazilian Participants With Rheumatoid Arthritis (RA) Who Completed the Studies ML21530 and MA21488

NCT01715831 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: DMARDs
DRUG: Tocilizumab

Sponsor

Hoffmann-La Roche